A phase II study of laquinimod in Crohn's disease

OBJECTIVE: Laquinimod is an oral therapeutic agent under investigation for the treatment of Crohn's disease (CD), Huntington's disease, lupus nephritis and multiple sclerosis. This dose escalation study evaluated the safety and efficacy of laquinimod as induction therapy in patients with a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Gut
Main Authors: D'Haens, Geert, Sandborn, William J, Colombel, Jean Frederic, Rutgeerts, Paul, Brown, Kurt, Barkay, Hadas, Sakov, Anat, Haviv, Asi, Feagan, Brian G
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2015
Fag:
Inflammatory Bowel Disease
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4515993/
https://ncbi.nlm.nih.gov/pubmed/25281416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2014-307118
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker